Aviation Medication Transparency Act of 2025

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 3258 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                S. 3258

To require the Administrator of the Federal Aviation Administration to 
publish the list of medications that the Administrator has compiled for 
purposes of the medical certification of airmen and air traffic control 
                  specialists, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           November 20, 2025

  Ms. Duckworth (for herself, Mr. Hoeven, Mr. Durbin, and Mrs. Britt) 
introduced the following bill; which was read twice and referred to the 
           Committee on Commerce, Science, and Transportation

_______________________________________________________________________

                                 A BILL


 
To require the Administrator of the Federal Aviation Administration to 
publish the list of medications that the Administrator has compiled for 
purposes of the medical certification of airmen and air traffic control 
                  specialists, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Aviation Medication Transparency Act 
of 2025''.

SEC. 2. AVIATION MEDICATION TRANSPARENCY; LIST OF APPROVED MEDICATIONS.

    (a) Purpose.--The purpose of this Act is to ensure that aviation 
stakeholders, including airmen, air traffic control specialists, and 
individuals training to become airmen or air traffic control 
specialists, who are applicants for medical certification are informed, 
in a user-friendly and accessible manner, of the medications they may 
be safely prescribed.
    (b) In General.--Not later than 1 year after the date of enactment 
of this Act, the Administrator of the Federal Aviation Administration 
(in this section referred to as the ``Administrator'') shall publish 
and maintain on a publicly available website of the Federal Aviation 
Administration (in this section referred to as the ``FAA'') a list of 
medications that the Administrator, as of the date of publication, 
has--
            (1) determined may be safely prescribed to an applicant for 
        medical certification to treat certain medical conditions; and
            (2) approved for purposes of the issuance of a medical 
        certification to an airman or air traffic control specialist.
    (c) Requirements.--To ensure medical appropriateness, user-
friendliness, and appropriate dissemination, the list required under 
subsection (b) shall--
            (1) be drafted in consultation with--
                    (A) the Aeromedical Innovation and Modernization 
                Working Group (established under section 411(a) of the 
                FAA Reauthorization Act of 2024 (49 U.S.C. 44703 note)) 
                (in this section referred to as the ``Working Group'');
                    (B) institutions of higher education that are 
                accredited by the Aviation Accreditation Board 
                International;
                    (C) the certified exclusive bargaining 
                representatives of air traffic controllers of the FAA 
                certified under section 7111 of title 5, United States 
                Code;
                    (D) organizations representing certified collective 
                bargaining representative of airline pilots; and
                    (E) any other stakeholder determined relevant by 
                the Working Group;
            (2) cover all medications approved by the Administrator, 
        including prescription medications and over-the-counter 
        medications;
            (3) be drafted in a user-friendly and accessible manner and 
        provided to airmen, air traffic control specialists, and 
        individuals training to become airmen or air traffic control 
        specialists at the time when any such individual first seeks a 
        medical certification;
            (4) if applicable, indicate the minimum and average period 
        of time an airman or air traffic control specialist is required 
        to have limited or no duties to stabilize on an approved 
        medication;
            (5) include the list of medications that the Administrator 
        has designated as ``Do Not Issue'';
            (6) include information for doctors or medical providers to 
        contact the FAA regarding questions related to such list, 
        including through a new or existing mechanism that is 
        accessible to such doctors and medical providers;
            (7) include any additional information that the 
        Administrator determines is appropriate to provide with respect 
        to what conditions a certain medication may or may not be used 
        to treat, as well as any information to explain why a 
        medication is allowed or prohibited by the FAA; and
            (8) include any other information or clarification that the 
        Administrator determines appropriate.
    (d) Annual Update.--Not later than 1 year after the date of 
publication of the list required under subsection (b), and annually 
thereafter, the Administrator shall update such list, as appropriate.
                                 <all>